Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

TMO A A DGX Emerging Markets Convertibles Wireless Junk Bonds 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Processing. Please wait...

ICON insider: Stephen Cutler

       

Stephen Cutler - ICON Insider Profile

Group President - Clinical Research Services

Dr. Stephen A. Cutler, Ph.D., is Group President Clinical Research Services of Icon PLC., since November 2011. Prior to joining the Company Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management Europe; and Vice President, Oncology Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles Dr. Cutler held positions with Sandoz in Australia and Europe. He holds a B.Sc. and a Ph.D from the University of Sydney and a Masters of Business Administration from the University of Birmingham .
Age: 50  President Since 2011      
353 1 291 2000  http://www.iconplc.com

Other Appointments

KEYnotes First Trust Enh 130-30JFTUnited States NYSEArca
Executive since 2007
JPMorgan 2X Short US Long Trsy DSTJUnited States NYSEArca
Executive since 2007
JPMorgan Chase CoJPMUnited States NYSE
Executive since 2007
JPMorgan Chase CoJPMArgentina Buenos-Aires
Executive since 2007
JPMorgan Alerian MLP Index ETNAMJUnited States NYSEArca
Executive since 2007
JPMorgan 2X Short US 10 Yr TrsyDSXJUnited States NYSEArca
Executive since 2007
JPMorgan Chase CoJPMMexico Mexico
Executive since 2007
JP MORG CHASE IDRJPMCBelgium Brussels
Executive since 2007
JP MORGAN CHASEJFTTLUnited States OTC
Executive since 2007

Management Efficency

The company has return on total asset (ROA) of 4.74 % which means that it generated profit of $4.74 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 8.91 % meaning that it created $8.91 on every $100 dollars invested by stockholders.
The company currently holds 20 M in liabilities with Debt to Equity (D/E) ratio of 0.03 which may suggest the company is not taking enough advantage from borrowing. ICON Public Limited Company has Current Ratio of 1.5 which is within standard range for the sector.
    

Other Executives

Peter Gray, Chairman
Bruce Given, Chairman, Ph.D
Ciaran Murray, Chairman
Brendan Brennan, CFO
Guy Dewil, COO
Ronan Lambe, Director
John Climax, Director
Cathrin Petty, Director
William Hall, Director
Thomas Lynch, Director
Dermot Kelleher, Director
Ronan MSC, Director
Declan McKeon, Director
Sam Farthing, Executive

Entity Summary

ICON Public Limited Company, a contract research organization, offer outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe. ICON Public Limited Company [ICLR] is traded on NASDAQ in USA. It is located in Dublin, and employs 10,200 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
ICLR United States Nasdaq
ICON Public Limited Company
Benchmark S&P 500
Currency: USD - US Dollar
Traded on NASDAQ
    
    
Chance of
Bankruptcy
Less
Than
1%
In The Next
Two Years
ICON Public Limited Company has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

ICON price boundaries

    
May 22 2013
 33.30 
  
 33.14 
(0.16)  Macroaxis: -0.4804804804804703 Down   0.48%  
Lowest period price (30 days)
June 17 2013
 35.44 
  
 35.94 
0.50  Macroaxis: 1.4108352144469527 Up   1.41%  
Highest period price (30 days)
    

Promote ICON and Stephen Cutler

Follow ICON with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add ICON to your reader
 

Today Change

 United States Russel   1.23 % Macroaxis: change 1.23 Moved Up  
 
 United States SP 500   0.78 % Macroaxis: 0.78 Moved Up  
 
 thisGreen ICLR ICLR agains markets  0.78 % Macroaxis: 0.78 Moved Up  
 
 United States NYSE   0.66 % Macroaxis: 0.66 Moved Up  
 

Stock Performance

Shares Outstanding60.54 M
Number of Shares Shorted676.83 K


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium